Evidence map›Paper›PMID 25137310›Full record

ArticleJournal of the American Chemical Society2014

Enantioselective olefin metathesis with cyclometalated ruthenium complexes.

John Hartung, Peter K Dornan, Robert H Grubbs

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Cationic ruthenium alkylidene catalysts bearing phosphine ligands.Dalton transactions (Cambridge, England : 2003) · 2016
    Article
  17. Tandem Z-Selective Cross-Metathesis/Dihydroxylation: Synthesis of anti-1,2-Diols.Angewandte Chemie (International ed. in English) · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

John HartungArnold and Mabel Beckman Laboratories of Chemical Synthesis, Division of Chemistry and Chemical Engineering, California Institute of Technology , Pasadena, California 91125, United States.
Peter K Dornan
Robert H Grubbs

Funding

REAGENTS FOR ORGANIC SYNTHESIS BASED ON TRANSITION METALR01GM031332 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI GRUBBS, ROBERT HOWARD · 1985 to 2016
$6.1M
400 MHz Nuclear Magnetic Resonance SpectrometerS10RR027690 · NCRR · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI VANDERVELDE, DAVID G · 2010 to 2010
$315k
NCRR NIH HHS RR027690NCRR NIH HHS S10 RR027690NIGMS NIH HHS 5R01GM031332-27NIGMS NIH HHS R01 GM031332
6 · The paper itself

Abstract

The success of enantioselective olefin metathesis relies on the design of enantioenriched alkylidene complexes capable of transferring stereochemical information from the catalyst structure to the reactants. Cyclometalation of the NHC ligand has proven to be a successful strategy to incorporate stereogenic atoms into the catalyst structure. Enantioenriched complexes incorporating this design element catalyze highly Z- and enantioselective asymmetric ring opening/cross metathesis (AROCM) of norbornenes and cyclobutenes, and the difference in ring strain between these two substrates leads to different propagating species in the catalytic cycle. Asymmetric ring closing metathesis (ARCM) of a challenging class of prochiral trienes has also been achieved. The extent of reversibility and effect of reaction setup was also explored. Finally, promising levels of enantioselectivity in an unprecedented Z-selective asymmetric cross metathesis (ACM) of a prochiral 1,4-diene was demonstrated.

Indexed as

AlkenesCoordination ComplexesCyclizationCyclobutanesModels, MolecularNorbornanesRutheniumStereoisomerismAlkenesCoordination ComplexesCyclobutanesNorbornanesRuthenium

Identifiers

PMID25137310
PMCPMC4183615

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.